Related Experiment Video
Updated: Aug 13, 2026

06:16
LipidUNet-Machine Learning-Based Method of Characterization and Quantification of Lipid Deposits Using iPSC-Derived Retinal Pigment Epithelium
Published on: July 28, 2023
In Vitro liposome release profile prediction using explainable machine learning approaches
Hamza Abu Owida1, Sameer Ahmad Hasan2, Areen Arabiat3
1Department of Medical Engineering, Faculty of Engineering, Al-Ahliyya Amman University, Amman, Jordan.
Plos One
|August 11, 2026
Summary
This study introduces an explainable machine learning workflow to classify liposomal drug release profiles. It identifies key formulation and testing factors influencing release rates, aiding in liposomal formulation development.
Area of Science:
- Pharmaceutical Sciences
- Computational Chemistry
- Biotechnology
Background:
- Liposomal in vitro release (IVR) profiles are influenced by formulation and testing conditions, making analysis complex.
- Understanding these multivariable associations is crucial for effective liposomal drug development.
Purpose of the Study:
- To develop an explainable computational workflow for classifying liposomal release phenotypes.
- To identify formulation and assay features associated with slow and fast liposomal release.
Main Methods:
- Benchmarking kinetic models and simulating Weibull-parameterized release curves.
- Clustering release profiles using Principal Component Analysis (PCA) and k-means clustering.
- Training supervised classifiers (XGBoost) on formulation and IVR descriptors using a public dataset.
Main Results:
- Three distinct kinetic phenotypes (slow, moderate, fast) were identified, with PCA explaining 98.4% of variance.
- XGBoost showed promising performance in classifying extreme slow vs. fast release subgroups.
- Key influential features identified include media pH, drug loading, lipid transition temperature, and media temperature.
Conclusions:
- Explainable machine learning can support risk-based IVR technique development and hypothesis generation for liposomal formulations.
- Prospective validation on independent datasets is necessary before clinical or regulatory application.
Related Concept Videos
Overview of Exosomes
Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
Modified-Release Drug Delivery Systems: Bioavailability
Modified-release (MR) dosage forms are designed to extend drug release over time, thereby maintaining stable plasma concentrations and reducing dosing frequency. However, their bioavailability is typically below 100% due to incomplete drug release and presystemic metabolism, and limitations in drug permeability across the gastrointestinal epithelium, all of which can restrict the fraction of the drug reaching systemic circulation. Consequently, studying the in vivo bioavailability of MR...